BofA raises Merck stock price target to $141 on cancer drug potential

BofA raises Merck stock price target to $141 on cancer drug potential  Investing.com Canada

Summary aggregated from Investing.com Canada's public RSS feed. The full reporting belongs to Investing.com Canada — please read it on their site.